Get the Stockscreener App
0.8286
4.42%
-0.0383
After Hours:
.83
0.0014
+0.17%
Beyond Air Inc stock is traded at $0.8286, with a volume of 126.29K.
It is down -4.42% in the last 24 hours and down -20.71% over the past month.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
See More
Previous Close:
$0.8669
Open:
$0.87
24h Volume:
126.29K
Relative Volume:
0.02
Market Cap:
$8.72M
Revenue:
$1.78M
Net Income/Loss:
$-58.35M
P/E Ratio:
-0.5052
EPS:
-1.64
Net Cash Flow:
$-56.66M
1W Performance:
-14.89%
1M Performance:
-20.71%
6M Performance:
-62.51%
1Y Performance:
+195.19%
1-Day Range:
$0.8013
$0.8706
1-Week Range:
$0.7669
$0.9699
52-Week Range:
$0.1521
$4.78
Beyond Air Inc Stock (XAIR) Company Profile
Name
Beyond Air Inc
Sector
Industry
Phone
516-665-8200
Address
900 STEWART AVENUE, GARDEN CITY, NY
Compare XAIR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XAIR
Beyond Air Inc
|
0.8286 | 9.13M | 1.78M | -58.35M | -56.66M | -1.64 |
|
ABT
Abbott Laboratories
|
111.04 | 196.53B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
370.50 | 146.14B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
93.01 | 122.74B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.99 | 107.15B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
83.89 | 49.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-25 | Initiated | D. Boral Capital | Buy |
| Jun-25-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-28-23 | Initiated | Piper Sandler | Overweight |
| Jun-15-23 | Initiated | BTIG Research | Buy |
| Apr-28-21 | Initiated | Truist | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Outperform |
View All
Beyond Air Inc Stock (XAIR) Latest News
Beyond Air Inc (XAIR) Expands Focus on Nitric Oxide Therapies - Finviz
12 Best NASDAQ Penny Stocks to Buy According to Analysts - Insider Monkey
Published on: 2026-03-02 20:03:07 - baoquankhu1.vn
Bull Bear: Can Beyond Air Inc deliver consistent EPS growthJuly 2025 Setups & Stock Portfolio Risk Management - baoquankhu1.vn
XAIR Should I Buy - Intellectia AI
XAIR PE Ratio & Valuation, Is XAIR Overvalued - Intellectia AI
How The Narrative On Beyond Air (XAIR) Is Resetting Around LungFit PH And Delayed Approval - Yahoo Finance
Earnings Beat: What is the PEG ratio of Beyond Air IncJuly 2025 Final Week & Real-Time Chart Pattern Alerts - baoquankhu1.vn
XAIR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Beyond Air Inc (XAIR) Q3 2026 Earnings Call Highlights: Impressive Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Beyond Air Inc (XAIR) Q3 2026 Earnings Call Highlights: Impressi - GuruFocus
Balyasny Asset Management L.P. Increases Stake in Beyond Air Inc - GuruFocus
Beyond Air comments on review of high-dose nitric oxide therapy - Investing.com Nigeria
Beyond Air (XAIR) Highlights Potential of High-Dose Inhaled Nitr - GuruFocus
Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections - The Manila Times
Beyond Air, Inc. Highlights Comprehensive Review on High-Dose Inhaled Nitric Oxide as Potential Antimicrobial Therapy for Respiratory Infections - Quiver Quantitative
Beyond Air Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections - Bitget
High-dose inhaled gas shows promise against tough lung infections - Stock Titan
Published on: 2026-02-18 22:24:05 - baoquankhu1.vn
Analysis Recap: Is Beyond Air Inc showing insider buyingBuy Signal & AI Driven Stock Reports - baoquankhu1.vn
Aug Outlook: How liquid is Beyond Air Inc stockTrade Entry Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
XAIR Technical Analysis & ETF Price Forecast - Intellectia AI
Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket - Intellectia AI
MSN Money - MSN
Leishen Energy's FY2025 Financial Results Analysis - Intellectia AI
Analyst Warns: Failure of NeuroNOS Acquisition Could Pressure Beyond Air’s Strategy, Finances, and Stock Price - TipRanks
1 Reason I'd Buy Intuitive Surgical Stock and Never Sell - AOL.com
Beyond Air, Inc. (NASDAQ:XAIR) Q3 2026 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Beyond Air Q3 2026 sees revenue growth and cost cuts - Investing.com Nigeria
XAIR Technical Analysis & Stock Price Forecast - Intellectia AI
XAIR Maintains Revenue Outlook for Fiscal Year Ending 2026 - GuruFocus
Beyond Air (XAIR) Reports Strong Q3 Revenue With Promising Growt - GuruFocus
Beyond Air Shares Rise Intraday After Q3 FY2026 Revenue More Than Doubles; Loss Narrows on Cost Cuts - AlphaStreet News
Beyond Air Reports Strong Q3 Growth and Funding Extension - TipRanks
Beyond Air, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Beyond Air, Inc. SEC 10-Q Report - TradingView
XAIR: Quarterly revenue doubled and net loss narrowed, but additional funding is needed within a year - TradingView
Beyond Air XAIR Q3 2026 Earnings Call Transcript - The Globe and Mail
XAIR: Revenue up 105% year-over-year, with strong cost controls and global LungFit PH expansion - TradingView
Beyond Air Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update - marketscreener.com
BEYOND AIR INC (NASDAQ:XAIR) Posts Revenue Beat, Reaffirms Guidance in Q3 2026 - ChartMill
Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
How Beyond Air Inc. stock compares to market leadersJuly 2025 Gainers & Long Hold Capital Preservation Plans - mfd.ru
Beyond Air Earnings Preview - Benzinga
BEYOND AIR Q3 2026 Earnings Preview: Recent $XAIR Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Geopolitics Watch: Can Beyond Air Inc outperform under higher oil pricesWeekly Gains Summary & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Why Beyond Air Inc. stock is seen as undervaluedLayoff News & Precise Swing Trade Entry Alerts - mfd.ru
Warrants, note and asset deal reshape Beyond Air (NASDAQ: XAIR) - Stock Titan
Will Beyond Air Inc benefit from geopolitical trendsEarnings Summary Report & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Big Money Moves: Is Beyond Air Inc showing insider buyingJuly 2025 Patterns & Reliable Intraday Trade Alerts - baoquankhu1.vn
Beyond Cancer to present Phase 1 UNO trial data at AACR meeting - Investing.com Australia
Beyond Air Inc Stock (XAIR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):